快科技3月30日消息,AMD RX 9070系列首次没有发售公版卡,但官方确实设计了。网友“白给的盖欧卡”就得到了一块公版的RX 9070 XT,并进行了拆解。 可能是因为没打算卖,所以整卡设计显得不是那么精致,看起来有些粗糙,背部的AMD ...
Luckily, the Lexus RX hybrid car has been well received over the years. We’ll include what it's like to drive, how pleasant it is for passengers, what safety kit it has and whether you'll find ...
We reviewed the RX 9070 XT, and its gaming and synthetic performance blew us away. Not only was it capable of outperforming its alternatives, but the RDNA 4 architecture also allowed it to trade blows ...
AMD has officially stated that there is an RX 9060 series and that it will be arriving in Q2 of this year. That means an AMD Radeon RX 9060 and potentially an AMD Radeon RX 9060 XT will be ...
Thanks to RDNA 4 ray-tracing and FSR 4, the Radeon RX 9070 presents a viable alternative to the GeForce RTX 5070. But at the same price point, the DLSS advantage wins. Ultimately, the Radeon RX ...
So, we'll use that to compare them, but this is purely a specs comparison, and till we have real-world benchmarks, we won't be able to move past speculations. The RX 9070 XT and the RX 9070 have 64 ...
AMD might have surrendered the high end of the GPU market, but its new $549 Radeon RX 9070 and $599 RX 9070 XT look set to bring Nvidia back to reality, at least in the midrange. The RX 9070 is ...
在说到RX 9070系列显卡的时候,苏姿丰表示:“当然,大家都喜欢非常高端的GPU,但不是人人都负担得起。 RX 9070 XT取得了巨大的成功,首周销量是上一代的10多倍,成为AMD显卡历史上最成功的产品。 我们对此激动万分。” ...
The Radeon RX 9070 and 9070 XT offer much faster performance and more memory than Nvidia’s lackluster RTX 5070. Some software bugs mar the experience but overall, AMD’s 9070 graphics cards ...
AMD kicks off its latest generation of graphics cards with a stunning release in the AMD Radeon RX 9070 XT, delivering RTX 4080-levels of gaming performance at half that card's launch MSRP.
After a hectic launch period, we're still monitoring retailers for the latest AMD Radeon RX 9070 XT and RX 9070 stock updates. The bad news: all US retailers are currently sold out. There is some ...
DocMorris AG (XSWX:DOCM) reports a 7% revenue increase, profitability in non-RX business, and plans a CHF200 million capital ...